Deflin Gayle 4
4 · Amphastar Pharmaceuticals, Inc. · Filed Jun 3, 2026
Research Summary
AI-generated summary of this filing
Amphastar (AMPH) Director Gayle Receives 25,508 RSUs
What Happened
Director Gayle received two awards on June 1, 2026 totaling 25,508 shares: 8,143 shares reported as restricted stock units (RSUs) and 17,365 shares reported as a derivative award. Both awards were recorded at $0.00 (no cash paid) on the Form 4 filed June 3, 2026. These are grants/awards (A), not open-market purchases or sales.
Key Details
- Transaction date: 2026-06-01; Form 4 filed: 2026-06-03 (timely filing).
- Awards: 8,143 RSUs @ $0.00; 17,365 derivative shares @ $0.00 — total 25,508 shares granted.
- Vesting: Footnote(s) indicate the RSUs and the shares subject to the option both vest on June 1, 2027.
- Shares owned after transaction: Not disclosed on the provided Form 4 excerpt.
- No sale or exercise occurred; this is an equity grant (code A), not a purchase (P) or sale (S).
Context
RSUs and similar derivative awards are compensation that convert to actual shares only when they vest; they do not represent immediate market selling or buying pressure. Because no cash changed hands and the awards vest in one year, this filing documents a standard director equity grant rather than an insider market trade.
Insider Transaction Report
- Award
Common Stock
[F1]2026-06-01+8,143→ 19,057 total - Award
Stock Option (right to buy)
[F2]2026-06-01+17,365→ 17,365 totalExercise: $18.42Exp: 2036-06-01→ Common Stock (17,365 underlying)
Footnotes (2)
- [F1]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 1, 2027.
- [F2]All of the shares subject to the option vest on June 1, 2027.